Authors


Maximilian K. Köppe, MD

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

New acrylic implant provides option for patients with endothelial dysfunction.


Vikram Paranjpe MD, MPH

Latest:

BLOG: The PTVT Trial and Clinical Applications

Joseph F. Panarelli MD, Steven J. Gedde, MD, and Vikram Paranjpe MD, MPH discuss the Primary Tube Versus Trabeculectomy (PTVT) study.


Maryo Kohen, MD

Latest:

The search for an antifibrotic drug for use with pediatric glaucoma devices

Inflammation and scarring are the primary obstacles with pirfenidone.


Lisa M. Nijm, MD, JD​

Latest:

Rethinking dry eye disease with acute steroid treatment

According to Lisa Nijm, MD, JD, patients can benefit from short-term, on-label treatment with a novel loteprednol formulation


Elizabeth Fortin, MD

Latest:

NeuroOp Guru: Neuro-Ophthalmology interprofessional eConsults

Andrew Lee, MD, Andrew Carey, MD, and Elizabeth Fortin, MD, sit down on this episode of the NeuroOp Guru to discuss neuro-ophthalmology, interprofessional eConsults, and whether they provide timely and valuable guidance


Darren Gregory, MD

Latest:

Pediatric ocular surface reconstruction: Managing lesion excision challenges

This population requires careful attention from diagnosis through the entire postoperative process.


Zaiba Malik, MD

Latest:

Beyond mentoring: The power of sponsorship and advocacy in ophthalmology

To create lasting change, ophthalmology must embrace the impact of sponsorship and advocacy—empowering the next generation of leaders with not just knowledge, but the opportunities to excel.


Jason R. Chin, OD, FAAO

Latest:

Increasing your practice’s reach, relevance, and revenue with clinical trials

Working as an investigator can prove to be a positive experience for physicians


J. Fernando Arevalo, MD, PhD, FACS, FASRS

Latest:

Q&A: The ELEVATUM Study with J. Fernando Arevalo

The ELEVATUM study explored faricimab's effectiveness in treating diabetic macular edema among underrepresented minorities, showcasing significant visual acuity improvements.


Carol Nelson, MD

Latest:

Treating traumatic brain injury neuro-optometrically

Physicians note the impact of prism lenses can be life-changing for patients.


Matt Hoffman

Latest:

Ravi Patel, MD, shares ASCRS 2025 insights on enVista ASPIRE IOL user experience

Discover how real-world evidence shapes cataract surgery practices, highlighting user satisfaction with enhanced monofocal IOLs at the 2025 ASCRS Annual Meeting.


Talia R. Kaden, MD​

Latest:

A Case of Neovascular AMD With Recurrent Subretinal Fluid

A retina specialist analyzes a case of neovascular age-related macular degeneration characterized by recurring subretinal fluid.



Sophie J. Bakri, MD

Latest:

Unmet Needs and the Future of Wet AMD Care

Expert panelists provide an overview of current unmet needs in wet AMD care and discuss the potential for improving clinical outcomes and treatment burden.


Imane Tarib, MD

Latest:

Tackling negotiations for contracts

On the 'Negotiations' episode of RWO: The Podcast, Dr. Lisa Nijm joins Drs. Nicole Bajic and Grayson Armstrong to discuss personal experiences with contract negotiation.


Randolph Young

Latest:

Tear film imager may shift paradigm in the treatment of dry eye disease

TFI employs spectral interference technology to image and map the corneal surface.


Steven Greenstein, MD

Latest:

Bridging disciplines and elevating care: A Q&A with John Gelles, OD, and Steven Greenstein, MD

In this Q&A, John D. Gelles, OD, and Steven Greenstein, MD, chat about what inspired them to launch the symposium, what makes this year’s agenda especially exciting, and why the future of refractive care depends on stronger collaboration between ODs and MDs.


Shehzad Batliwala, DO

Latest:

ASCRS 2025: Pinpointing your "why" and brushing up on clinical skills are vital to humanitarian ophthalmology

Shehzad Batliwala, DO, known to his patients as Dr. Shehz, appeared on the ASCRS Foundation Symposium, where he discussed performing refractive surgery in low-resource, high-risk areas.


Mike Farkas, PhD

Latest:

Envision Summit 2025: Beyond the status quo in gene therapy

At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal degenerations that sidetracks the current "status quo" therapies of AAV-based replacement and CRISPR-Cas9 genome editing.


Emma Lessieur-Contreras, MD, PhD

Latest:

ARVO 2025: Retina extracellular vesicles in diabetic retinopathy

At ARVO 2025, in Salt Lake City, Utah, Emma Lessieur-Contreras, MD, PhD, talked about her poster on retina extracellular vesicles, and the role that they play on diabetic retinopathy.


Malvina Eydelman, MD

Latest:

Q&A: Malvina Eydelman, MD, on leading CCOI and catalyzing global ophthalmic innovation

Shifting from a regulatory role to driving innovation directly, Eydelman discusses how the Collaborative Community on Ophthalmic Innovation is reshaping the field, streamlining outdated processes, and advancing patient-centered solutions worldwide.



Yassine Daoud, MD, FACS

Latest:

Presbyopia treatment success begins with patient-centered care

Personalizing treatment options and setting realistic expectations are crucial.


Rachel Simpson, MD

Latest:

Envision Summit 2025: New developments in glaucoma treatment and tailoring them to the patient

At the Envision Summit 2025 in San Juan, Puerto Rico, Rachel Simpson, MD, talked about new developments in glaucoma treatment and really how to tailor glaucoma treatment to the patient.



Patti Barkey, COE, OCS

Latest:

Pass-through provides vehicle to drive innovation

As more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.


Nitish Mehta, MD

Latest:

The Residency Report: Study provides new insights into USH2A target end points

Researchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration


Nathan Congdon

Latest:

Children’s mental health and the impact of vision impairment

Two studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.


Douglas Katsev, MD

Latest:

Payment models for imaging: Procedures not covered by insurance policies

Tips to help eye care providers navigate the maze of insurance issues.


Anoud Al Saati, MD

Latest:

Posterior corneal elevation: Is there a role for premium IOLs?

Trifocal IOLs can, if implanted with caution, be suitable for patients with keratoconus.

© 2025 MJH Life Sciences

All rights reserved.